Virtus Biotech ETF
BBP
13 hedge funds and large institutions have $5.89M invested in Virtus Biotech ETF in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
15% more capital invested
Capital invested by funds: $5.14M → $5.89M (+$752K)
4.25% more ownership
Funds ownership: 24.45% → 28.7% (+4.3%)
0% more funds holding
Funds holding: 13 → 13 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Raymond James Financial
St Petersburg,
Florida
|
+$1.03M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$749K |
| 3 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$72.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$14.8K |
| 5 |
IFG
Independent Financial Group
San Diego,
California
|
+$9.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$515K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$294K |
| 3 |
LPL Financial
San Diego,
California
|
-$118K |
| 4 |
CAMG
CWA Asset Management Group
Naples,
Florida
|
-$40.2K |
BBP Hedge Fund Activity: Q1 2025 in Review
13 of the 7,464 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q1 2025, worth a combined $5.89M — up 15% from $5.14M a quarter earlier.
Fund positioning in BBP was balanced in Q1 2025: 1 fund opened new positions, 1 closed out, 6 added to existing stakes and 3 trimmed.
The largest buyer was Raymond James Financial, adding an estimated $1.03M. The largest seller was Royal Bank of Canada, cutting an estimated $515K.
- 13 institutional investors held Virtus Biotech ETF (BBP) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $5.89M of Virtus Biotech ETF stock for Q1 2025, up 15% quarter-over-quarter.
- 1 fund opened new Virtus Biotech ETF positions in Q1 2025 and 1 closed out, a net change of 0 holders.
- The largest Virtus Biotech ETF buyer in Q1 2025 was Raymond James Financial, an estimated $1.03M added.
- The largest Virtus Biotech ETF seller in Q1 2025 was Royal Bank of Canada, an estimated $515K sold.
Based on aggregated 13F filings for Q1 2025.